Delivery Order SPE2DB25D2204-SPE2DB25FTGWP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.81 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of August 28, 2025. This non-set-aside, competitively awarded contract reflects firm fixed-price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion through December 2026. The place of performance is located at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with performance in Conshohocken, Pennsylvania and completion by July 23, 2025. This contract was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing typical of DLA pharmaceutical procurement. Valtoco is a rescue medication indicated for acute repetitive seizure episodes, reflecting the broad therapeutic scope of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Valtoco 15 mg nasal spray, a medication used for acute seizure management. This firm fixed-price delivery order, valued at $3,385.62, represents a non-competitive set-aside contract and is scheduled for completion by July 24, 2025. The award was issued from the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, valued at $2,257.08 under firm fixed pricing. This delivery order, issued on July 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $5,067.89 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $5,644.86 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal sprays. This firm fixed-price contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Valtoco 15 mg nasal sprays, valued at $2,372.64. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 and extends through December 2026. The contract carries no set-aside designation and reflects...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of September 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 11, 2025, for the supply of Valtoco 10 mg nasal sprays. The contract is valued at $1,616.58 and carries a completion date of July 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through the company's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $6,726.02 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 25, 2025. This firm fixed-price contract, awarded on August 22, 2025, was not set-aside and represents a competitively awarded delivery order. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Valtoco is a critical emergency medication used primarily for acute seizure...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGWPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,173.67 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with performance completion required by August 15, 2025. This firm fixed-price contract, awarded on August 14, 2025, represents a non-set-aside competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used in emergency seizure management, reflecting the breadth of pharmaceutical products AmerisourceBergen supplies to support federal military and veteran healthcare systems. This delivery order is a child contract under AmerisourceBergen's $999.99 billion Indefinite Delivery/Indefinite Quantity (IDIQ) prime contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, maintains a substantial portfolio of federal contracts with the DLA covering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/14/25 |